(Q37684174)

22 August 2017

1 reference

title

Circulating tumour cells in clinical practice: Methods of detection and possible characterization (English)

1 reference

22 August 2017

author name string

Marianna Alunni-Fabbroni

series ordinal

1

1 reference

22 August 2017

Maria Teresa Sandri

series ordinal

2

1 reference

22 August 2017

language of work or name

1 reference

29 January 2010

1 reference

22 August 2017

1 reference

22 August 2017

volume

50

1 reference

22 August 2017

issue

4

1 reference

22 August 2017

page(s)

289-297

1 reference

Prognostic significance of occult lymph node metastases in node-negative breast cancer

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.01.027

Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.01.027

Isolation by size of epithelial tumor cells : a new method for the immunomorphological and molecular characterization of circulatingtumor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.01.027

Detection of circulating tumor cells in blood using an optimized density gradient centrifugation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.01.027

Circulating tumor cells in breast cancer: correlation to bone marrow micrometastases, heterogeneous response to systemic therapy and low proliferative activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.01.027

Detection of isolated tumor cells in peripheral blood and in BM: evaluation of a new enrichment method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.01.027

Pitfalls in the detection of disseminated non-hematological tumor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.01.027

Large-scale isolation of CD34+ cells using the Amgen cell selection device results in high levels of purity and recovery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.01.027

Quantitative real-time RT-PCR of disseminated tumor cells in combination with immunomagnetic cell enrichment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.01.027

Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.01.027

Detection of micrometastasis by cytokeratin 20 RT-PCR is limited due to stable background transcription in granulocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.01.027

Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.01.027

Complex networks orchestrate epithelial-mesenchymal transitions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.01.027

Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.01.027

Response of circulating tumor cells to systemic therapy in patients with metastatic breast cancer: comparison of quantitative polymerase chain reaction and immunocytochemical techniques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.01.027

Detection of micrometastatic cells in breast cancer by RT-pCR for the mammaglobin gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.01.027

Quantitative detection of circulating epithelial cells by Q-RT-PCR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.01.027

Predictive and prognostic value of peripheral blood cytokeratin-19 mRNA-positive cells detected by real-time polymerase chain reaction in node-negative breast cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.01.027

Molecular detection of circulating tumor cells in the peripheral blood of patients with colorectal cancer using RT-PCR: significance of the prediction of postoperative metastasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.01.027

Detection, clinical relevance and specific biological properties of disseminating tumour cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.01.027

7 January 2021

Cancer micrometastases

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.01.027

Circulating tumor cells (CTCs): detection methods and their clinical relevance in breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.01.027

Quantification of mRNA using real-time RT-PCR

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.01.027

A highly specific real-time RT-PCR method for the quantitative determination of CK-19 mRNA positive cells in peripheral blood of patients with operable breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.01.027

Detection of circulating tumour cells in blood by quantitative real-time RT-PCR: effect of pre-analytical time.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.01.027

Optimal markers for real-time quantitative reverse transcription PCR detection of circulating tumor cells from melanoma, breast, colon, esophageal, head and neck, and lung cancers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.01.027

High speed detection of circulating tumor cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.01.027

A rare-cell detector for cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.01.027

Standardized quantification of circulating peripheral tumor cells from lung and breast cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.01.027

An increase in cell number at completion of therapy may develop as an indicator of early relapse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.01.027

Evaluation of multiparameter flow cytometry for the detection of breast cancer tumor cells in blood samples

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.01.027

Automated screening for micrometastases in bone marrow smears

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.01.027

Detection of immunocytochemically stained rare events using image analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.01.027

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.01.027

Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.01.027

Circulating Tumor Cell Number and Prognosis in Progressive Castration-Resistant Prostate Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.01.027

Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.01.027

Isolation of rare circulating tumour cells in cancer patients by microchip technology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.01.027

Detection and characterization of putative metastatic precursor cells in cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.01.027

Characterization and enumeration of cells secreting tumor markers in the peripheral blood of breast cancer patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.01.027

Adult BM generates CD5+ B1 cells containing abundant N-region additions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.01.027

Regulation of astrocyte inflammatory responses by the Parkinson's disease-associated gene DJ-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.01.027

Circulating tumor cells in patients with breast cancer dormancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.01.027

HER-2 gene amplification can be acquired as breast cancer progresses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.01.027

From latent disseminated cells to overt metastasis: genetic analysis of systemic breast cancer progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.01.027

Variation of circulating tumor cell levels during treatment of metastatic breast cancer: prognostic and therapeutic implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.01.027

Molecular detection of cytokeratin-19-positive cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.01.027

Different prognostic value of cytokeratin-19 mRNA positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.01.027

Circulating HER2 mRNA-positive cells in the peripheral blood of patients with stage I and II breast cancer after the administration of adjuvant chemotherapy: evaluation of their clinical relevance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.01.027

Cytokeratin-19 mRNA-positive circulating tumor cells after adjuvant chemotherapy in patients with early breast cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.01.027

Circulating tumor cells versus imaging--predicting overall survival in metastatic breast cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.01.027

Circulating tumor cell detection predicts early metastatic relapse after neoadjuvant chemotherapy in large operable and locally advanced breast cancer in a phase II randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.01.027

Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.01.027

Determination of HER2 status using both serum HER2 levels and circulating tumor cells in patients with recurrent breast cancer whose primary tumor was HER2 negative or of unknown HER2 status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.01.027

uPAR and HER-2 gene status in individual breast cancer cells from blood and tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.01.027

Global gene expression profiling of circulating tumor cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.01.027

Breast cancer stem cells: implications for therapy of breast cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.01.027

10.1016/J.YMETH.2010.01.027

7 January 2021

Identifiers

DOI

1 reference

22 August 2017

1 reference